| 05/14/13 |
Suneva Medical Announces Results of Its Pivotal ArteFill® Acne Scar Study |
| 09/18/12 |
Suneva Medical Completes Enrollment and Initial Treatment of Patients in Phase III Acne Scar Study |
| 06/06/12 |
Suneva Medical Introduces ReGenica™, the Next Generation of Growth Factor Skincare |
| 05/21/12 |
Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals - Refissa Leads Suneva into the Topical Aesthetic Market |
| 03/05/12 |
Histogen Signs License Agreement with Suneva Medical for Cell Conditioned Media-based Aesthetic Products |
| 01/11/12 |
Suneva Medical to Pursue Expanded Indications for Artefill® with Launch of Phase III Acne Scar Study |
| 11/01/11 |
Even in This Economy, Consumers Invest in Aesthetic Procedures With Long Lasting Results |
| 06/29/11 |
Suneva Medical Announces Canadian Approval of Bellafill™ |
| 10/15/10 |
Nicholas L. Teti, Jr. Appointed President and CEO of Suneva Medical |
| 10/07/10 |
New Study Published in Journal of Drugs in Dermatology Finds Artefill Effective in Treating Atrophic Acne Scars |
| 05/07/10 |
Artefill® Featured on “The Doctors” Television Show |
| 05/05/10 |
Suneva Medical Announces Publication of Artefill® Five-Year Safety and Patient Satisfaction Study Interim Results in Dermatologic Surgery |
| 05/04/10 |
Leading Plastic Surgeons Report Positive Data on Artefill® at Key Society Meetings |
| 02/16/10 |
Leading U.S. Dermatologist Reports Positive Data on Artefill® |
| 02/02/10 |
Two Studies Find Artefill® to Be a Long-Term Treatment Option for Facial Lipoatrophy |
| 01/25/10 |
Suneva Medical Announces Positive Interim Data from Five-Year Safety and Patient Satisfaction Study on Artefill® |
| 01/18/10 |
Study Results Evaluating the Correction of Atrophic Scars with Artefill Presented at 2010 Orlando Dermatology Conference |
| 12/17/09 |
Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment |
Contact Suneva Medical